EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Art of Dosing for Subcutaneous Immunotherapy in North America

Harold S Nelson, Tricia Sowers, Greg Plunkett, Hendrik Nolte, Karen Rance

The Journal of Allergy and Clinical Immunology: In Practice · 2024

DOI: 10.1016/j.jaip.2023.06.036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024. Verfasst von Harold S Nelson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, National Jewish Health, Denver, Colo. Hauptthemen laut MEDLINE: Hypersensitivity, Sublingual Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subcutaneous immunotherapy (SCIT) is a long-established treatment option for allergic rhinoconjunctivitis. Proper dosing of the allergens is critical for the efficacy and safety of SCIT. Of the hundreds of liquid allergen extracts in the United States, effective and well-tolerated SCIT dosing has only been established for a small number. Thus, SCIT dosing remains largely empiric and continues to be, by necessity, an art. To highlight the complexity of SCIT dosing, this review summarizes the historical and current landscape of U.S. allergen extracts, differences among U.S. and European allergen extracts, allergen selection for SCIT, considerations for compounding of allergen extract mixtures, and recommended dosing. As of 2021, 18 standardized allergen extracts are available in the United States; all other extracts remain unstandardized without characterization of allergen content or potency. U.S. allergen extracts differ from European extracts in formulation and potency characterization. There is no standardized methodology for SCIT allergen selection, and interpretation of allergen sensitization is not straightforward. Compounding of SCIT mixtures requires consideration of potential dilution effects, allergen cross-reactivity, proteolytic activity, and additives. Probable effective dose ranges for SCIT are recommended in U.S. allergy immunotherapy practice parameters, although there are few studies using U.S. extracts supporting these doses as therapeutic. In contrast, optimized doses of sublingual immunotherapy tablets have been confirmed in North American phase 3 trials. The SCIT dosing for each patient remains an art that requires clinical experience and consideration of polysensitization, tolerability, compounding of allergen extract mixtures, and the range of recommended doses within the context of extract potency variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypersensitivitySublingual ImmunotherapyHumansAllergensDesensitization, ImmunologicInjections, SubcutaneousNorth AmericaPlant Extracts

Stichwörter der Autor:innen

Allergic rhinitisAllergy immunotherapyDosingExtractPolysensitizationSubcutaneous immunotherapy

Substanzen

AllergensPlant Extracts

Autor:innen und Institutionen

  • Department of Medicine, National Jewish Health, Denver, Colo.
  • Independent consultant, Austin, Texas.
  • Independent consultant, Mead, Wash.
  • ALK, Bedminster, NJ.
  • ALK, Bedminster, NJ. Electronic address: ksrance@gmail.com.

Zitieren

APA

Nelson, H. S., Sowers, T., Plunkett, G., Nolte, H., & Rance, K. (2024). The Art of Dosing for Subcutaneous Immunotherapy in North America. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.06.036

Vancouver

Nelson HS, Sowers T, Plunkett G, Nolte H, Rance K. The Art of Dosing for Subcutaneous Immunotherapy in North America. The Journal of Allergy and Clinical Immunology: In Practice. 2024. doi:10.1016/j.jaip.2023.06.036

BibTeX
@article{Nelson2024,
  author = {Nelson, Harold S and Sowers, Tricia and Plunkett, Greg and Nolte, Hendrik and Rance, Karen},
  title = {The Art of Dosing for Subcutaneous Immunotherapy in North America},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  doi = {10.1016/j.jaip.2023.06.036}
}
Kostenlos starten →